A BRIAN DAVIS
CIK 1184432 · Chief Financial Officer · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.0K
Companies
6
Total Filings
20
Lifetime Open-Market Net
$98.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GRCE | Director | — | $2.25 | — | $0 | 2 | 2026-01-12 |
| Grace Therapeutics, Inc. (ACST) Delisted | Director | — | $3.37 | — | $0 | 1 | 2023-12-20 |
| VRCA | Chief Financial Officer | 1,290 | $5.40 | $7.0K | $98.7K | 5 | 2021-06-07 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Financial Officer | 33,366 | $2.00 | $66.7K | $0 | 3 | 2019-02-22 |
| TENGION INC (TNGN) Delisted | Chf. Fin. Offr, VP Fin. | 9,167 | — | — | $0 | 3 | 2012-02-21 |
| NEOSE TECHNOLOGIES INC (NTEC) Delisted | Sr. Vice President and CFO | 33,650 | $9.63 | $324.0K | $0 | 5 | 2008-02-05 |
Recent Filings · Page 2 of 2
20 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-06 | Strongbridge Biopharma plc (SBBP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-03-06 | — | Tax (F) | −702 | -$878 | |
| 2012-02-21 | TENGION INC (TNGN) Delisted | Grant (A) | +68,333 | $0 | EDGAR |
| 2011-05-13 | TENGION INC (TNGN) Delisted | Grant (A) | +23,333 | $0 | EDGAR |
| 2010-08-03 | TENGION INC (TNGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-05 | NEOSE TECHNOLOGIES INC (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-08-08 | NEOSE TECHNOLOGIES INC (NTEC) Delisted | Mixed | +11,460 | -$9.4K | EDGAR |
| 2007-04-06 | NEOSE TECHNOLOGIES INC (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-03-29 | NEOSE TECHNOLOGIES INC (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-02-01 | NEOSE TECHNOLOGIES INC (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.